Genesco (NYSE:GCO) posted its quarterly earnings results on Thursday. The company reported $0.95 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.86 by $0.09, RTT News reports. The company had revenue of $713.10 million for the quarter, compared to the consensus estimate of $712.06 million. Genesco had a positive return on equity of 7.53% and a negative net margin of 3.77%. The firm’s quarterly revenue was down .5% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.02 EPS. Genesco updated its FY 2019 guidance to $3.10-3.40 EPS and its FY19 guidance to $3.15-3.40 EPS.

GCO opened at $42.91 on Thursday. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.43 and a quick ratio of 0.53. Genesco has a 12 month low of $27.20 and a 12 month high of $51.85. The firm has a market capitalization of $866.47 million, a P/E ratio of 13.67, a PEG ratio of 1.79 and a beta of 1.03.

Several institutional investors and hedge funds have recently added to or reduced their stakes in GCO. Raymond James & Associates increased its holdings in Genesco by 21.0% during the 2nd quarter. Raymond James & Associates now owns 29,480 shares of the company’s stock worth $1,170,000 after purchasing an additional 5,126 shares in the last quarter. AMP Capital Investors Ltd bought a new position in Genesco during the 2nd quarter worth about $292,000. Fox Run Management L.L.C. bought a new position in Genesco during the 3rd quarter worth about $467,000. Carillon Tower Advisers Inc. increased its holdings in Genesco by 1.3% during the 2nd quarter. Carillon Tower Advisers Inc. now owns 1,321,749 shares of the company’s stock worth $52,473,000 after purchasing an additional 17,469 shares in the last quarter. Finally, Valeo Financial Advisors LLC bought a new position in Genesco during the 2nd quarter worth about $1,625,000.

A number of research firms have recently weighed in on GCO. Pivotal Research raised Genesco from a “hold” rating to a “buy” rating and increased their price target for the company from $44.00 to $54.00 in a research note on Thursday, August 30th. Macquarie increased their price target on Genesco from $28.00 to $32.00 and gave the company a “hold” rating in a research note on Monday, September 10th. Zacks Investment Research raised Genesco from a “sell” rating to a “hold” rating and set a $53.00 price target on the stock in a research note on Tuesday, September 11th. ValuEngine raised Genesco from a “hold” rating to a “buy” rating in a research note on Tuesday, November 27th. Finally, Piper Jaffray Companies set a $41.00 price target on Genesco and gave the company a “hold” rating in a research note on Friday, November 30th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $41.78.

COPYRIGHT VIOLATION WARNING: “Genesco (GCO) Posts Earnings Results, Beats Estimates By $0.09 EPS” was posted by Watch List News and is the property of of Watch List News. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be read at https://www.watchlistnews.com/genesco-gco-posts-earnings-results-beats-estimates-by-0-09-eps/2664855.html.

Genesco Company Profile

Genesco Inc retails and wholesales footwear, apparel, and accessories. The company operates in five segments: Journeys Group, Schuh Group, Lids Sports Group, Johnston & Murphy Group, and Licensed Brands. The Journeys Group segment offers footwear and accessories through the Journeys, Journeys Kidz, Shi by Journeys, and Little Burgundy retail chains, as well as through e-commerce and catalogs for young men, women, and children.

Read More: Is the Dow Jones Industrial Average (DJIA) still relevant?

Earnings History for Genesco (NYSE:GCO)

Receive News & Ratings for Genesco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco and related companies with MarketBeat.com's FREE daily email newsletter.